Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Catch up on Q2 GI headlines you may have missed, including an expanded FDA approval for linaclotide, a submission for risankizumab SC induction in Crohn’s, and more.

Q2 2026 Recap: Gastroenterology News & Updates

The approval indicates linaclotide for pediatric patients ≥ 2 years of age with functional constipation, expanding its previous use in patients ≥ 6 years of age.

FDA Approves Linaclotide (Linzess) for Functional Constipation in Patients 2 Years And Older

Kyle Staller, MD, MPH, explains new real-world data showing 41% of IBS-C patients change treatments at least once, with each switch driving higher HCRU and provider portal burden.

Treatment Cycling in IBS-C Drives Greater Healthcare Resource Utilization

Catch up on new IBD drug trial data, regulatory actions, and updates in IBS in this April month in review.

5 Gastroenterology Headlines You Missed in April 2026

Early data suggest varenicline may improve abdominal pain, bloating, and bowel symptoms in patients with IBS.

Varenicline Shows Early Promise for Pain, Bowel Symptoms in IBS, With Ayah Matar, MD

IBS care is evolving with personalized, multimodal strategies, but gaps in access, education, and real-world outcomes continue to impact patients’ lives

Navigating Progress, Personalization, and Persistent Gaps in IBS Care

Rezaie explains how IBS care has shifted from symptom-based treatment to targeted, mechanism-driven strategies.

Rethinking IBS Management: The Shift Toward Precision Care, With Ali Rezaie, MD

New long-term data link antidepressant use in IBS to higher mortality risk. Rezaie explains key findings and clinical implications.

Are We Overlooking Long-Term Risks in IBS Management? New 20-Year Safety Data, With Ali Rezaie, MD

Q1 2026 GI updates include advances in IBD and IBS therapies, long-term data, and new insights into access challenges for younger patients.

Q1 2026 Recap: Gastroenterology News and Updates

Catch up on disparities in IBD care, a potential new IBS drug, new insight on diet’s role in Crohn’s disease care, & more.

6 Gastroenterology Headlines You Missed in January 2026

On the HCPLive irritable bowel syndrome page, resources on the topics of medical news and expert insight into IBS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBS, IBD, and more.

Irritable Bowel Syndrome